Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| GILEAD SCIENCES | 9 | 5 | +0,31 % | ||
| INVIVYD | 8 | 3 | 0,00 % | ||
| C4 THERAPEUTICS | 6 | 5 | 0,00 % | ||
| VANDA PHARMACEUTICALS | 6 | - | +0,80 % | ||
| NURIX THERAPEUTICS | 5 | 4 | 0,00 % | ||
| IMMUNITYBIO | 4 | 3 | +0,63 % | ||
| BIONTECH | 3 | 13 | -0,13 % | ||
| KYMERA THERAPEUTICS | 3 | 6 | +0,25 % | ||
| ZYMEWORKS | 3 | 5 | +0,39 % | ||
| JAZZ PHARMACEUTICALS | 3 | 1 | +0,41 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06:35 | Why Amaero, Mesoblast, Telix, and Tivan shares are charging higher today | 4 | The Motley Fool Australia | ||
| 00:26 | What's Driving Erasca (ERAS)'s Nearly 355% YTD Return | 2 | Insider Monkey | ||
| Do | Novocure: Uri Weinberg erhält Gehaltserhöhung für neue Doppelrolle | 2 | Investing.com Deutsch | ||
| Do | Raymond James stuft United Therapeutics mit "Outperform" ein - Kursziel 700 Dollar | 1 | Investing.com Deutsch | ||
| Do | Ionis: Raymond James startet Coverage mit "Outperform" und hohem Kursziel | 5 | Investing.com Deutsch | ||
| Do | Raymond James startet Coverage für Jazz Pharmaceuticals mit "Outperform" | 1 | Investing.com Deutsch | ||
| Do | Raymond James startet Coverage für PTC Therapeutics mit "Outperform" | 2 | Investing.com Deutsch | ||
| Do | Praxis Precision Medicines: Raymond James sieht Kurspotenzial von über 150 % | 1 | Investing.com Deutsch | ||
| Do | Raymond James initiates United Therapeutics stock coverage with outperform rating | 2 | Investing.com | ||
| Do | Raymond James initiates Insmed stock coverage with outperform rating | 5 | Investing.com | ||
| Do | Raymond James initiates Ionis stock with outperform rating | 5 | Investing.com | ||
| Do | Raymond James initiates Jazz Pharmaceuticals stock coverage with outperform rating | 3 | Investing.com | ||
| Do | Raymond James initiates PTC Therapeutics stock coverage with outperform rating | 1 | Investing.com | ||
| Do | Raymond James initiates Praxis Precision Medicines stock coverage with Strong Buy | 1 | Investing.com | ||
| Do | Gilead and Roche Bet on Protein Degraders for Their Cancer Drug Pipelines | 5 | MedCity News | ||
| Do | Goodwin berät Tubulis beim Verkauf an Gilead Sciences | 3 | Recht & Politik | ||
| Do | NovoCure Ltd - 8-K, Current Report | - | SEC Filings | ||
| Do | Invivyd reveals plans to test an antibody drug against measles | 1 | BioPharma Dive | ||
| Do | Vanda initiates study of motion sickness drug Nereus on GLP-1 users | 3 | FiercePharma | ||
| Do | Gossamer Bio, Inc. - 8-K, Current Report | - | SEC Filings |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.